Global Healthcare Analyst

Tina Banerjee

Thematic (Sector/Industry)

<ul>
<li>Hansoh Pharmaceutical entered outlicense agreement with Roche for upfront and milestone payments of $2B+. Leads Biolabs and Dianthus Therapeutics entered into exclusive global license agreement for pre-clinical asset.</li>
<li>Chugai Pharmaceutical’s partner Eli Lilly announced positive results from Phase 3 trials of orforglipron. SanBio Co announced that their partial change application for AKUUGO is one step ahead for approval.</li>
<li>Celltrion launched Actemra biosimilar, Aptozma in the U.S. at ~35% discount to original drug. Samsung Biologics shareholders approved biologics business spin-off plan to transform the company into a pure-play CDMO.</li>
</ul>


Hansoh Pharmaceutical entered outlicense agreement with Roche for upfront and milestone payments of $2B+. Leads Biolabs and Dianthus Therapeutics entered into exclusive global license agreement for pre-clinical asset.
Chugai Pharmaceutical’s partner Eli Lilly announced positive results from Phase 3 trials of orforglipron. SanBio Co announced that their partial change application for AKUUGO is one step ahead for approval.
Celltrion launched Actemra biosimilar, Aptozma in the U.S. at ~35% discount to original drug. Samsung Biologics shareholders approved biologics business spin-off plan to transform the company into a pure-play CDMO.


APAC Healthcare Weekly (October 19) – Hansoh, Leads Biolabs, Chugai, SanBio, Celltrion, Samsung Bio

Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Douglas Research Advisory

Cross Asset Strategy

<ul>
<li>KRX announced changes to KOSPI 200 and KOSDAQ 150 indices. In KOSPI 200, 6 were added and 6 were removed. In KOSDAQ 150, 13 were added and 13 were removed. </li>
<li>The six additions to KOSPI 200 had an average share price increase of 17.7% YTD. The six deletions had an average share price decline of 2.5% YTD.</li>
<li>One trading idea post the announcement of the KOSPI 200 and KOSDAQ 150 rebalances is to highlight the potential underperformers (including 20 lowest market cap stocks in KOSPI200/KOSDAQ150 post rebalance). </li>
</ul>


KRX announced changes to KOSPI 200 and KOSDAQ 150 indices. In KOSPI 200, 6 were added and 6 were removed. In KOSDAQ 150, 13 were added and 13 were removed. 
The six additions to KOSPI 200 had an average share price increase of 17.7% YTD. The six deletions had an average share price decline of 2.5% YTD.
One trading idea post the announcement of the KOSPI 200 and KOSDAQ 150 rebalances is to highlight the potential underperformers (including 20 lowest market cap stocks in KOSPI200/KOSDAQ150 post rebalance). 


Trading Idea Post Changes to KOSPI 200 and KOSDAQ 150

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of KRX stocks as of Jun 5th. The aggregated short interest was USD17.9bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in SAMSUNG C&amp;T, NAVER, LG Electronics, LG Innotek, SamsungElecMech.</li>
</ul>


We analyzed the changes in short interest of KRX stocks as of Jun 5th. The aggregated short interest was USD17.9bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in SAMSUNG C&amp;T, NAVER, LG Electronics, LG Innotek, SamsungElecMech.


KRX Short Interest Weekly (Jun 5th): SAMSUNG C&T, NAVER, LG Electronics, LG Innotek, SamsungElecMech

<ul>
<li>We analyzed the changes in short interest of KRX stocks as of May 22nd. The aggregated short interest was USD18.5bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Mobis, HyundaiEng&amp;Const, LG Display, DB HiTek, JEL.</li>
</ul>


We analyzed the changes in short interest of KRX stocks as of May 22nd. The aggregated short interest was USD18.5bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Mobis, HyundaiEng&amp;Const, LG Display, DB HiTek, JEL.


KRX Short Interest Weekly (May 22nd): Mobis, HyundaiEng&Const, LG Display, DB HiTek, JEL

Index Rebalance

<ul>
<li><em><strong>On 22 May, the Korea Exchange announced its regular bi-annual constituent rebalance changes in KOSPI 200 and KOSDAQ 150 indices, effective 12 June 2026.   </strong></em></li>
<li>In KOSPI 200 index, four stocks were added and four were removed. Four stocks that are newly added include Hyundai Construction Equipment, d'Alba Global, OCI Co, and DB Hitek. </li>
<li>There were 16 new inclusions and 16 exclusions in the KOSDAQ 150 index rebalance changes. </li>
</ul>


On 22 May, the Korea Exchange announced its regular bi-annual constituent rebalance changes in KOSPI 200 and KOSDAQ 150 indices, effective 12 June 2026.   
In KOSPI 200 index, four stocks were added and four were removed. Four stocks that are newly added include Hyundai Construction Equipment, d'Alba Global, OCI Co, and DB Hitek. 
There were 16 new inclusions and 16 exclusions in the KOSDAQ 150 index rebalance changes. 


KOSPI 200 and KOSDAQ 150 Indices Rebalance Announcements for June 2026

South Korea

Green Cross Holdings Corporation is a holding company, which operates pharmaceutical, biotechnology, distribution system, life insurance, and healthcare entities.  The Company also invests in biotechnology venture capital and markets medical research information.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Green Cross Holdings (005250 KS)

APAC Healthcare Weekly (October 19) – Hansoh, Leads Biolabs, Chugai, SanBio, Celltrion, Samsung Bio

Hansoh and Leads Biolabs bag global outlicensing deals. Chugai’s partner Lilly announced positive P3 result for orforglipron. Celltrion launched...

Tina Banerjee

Trading Idea Post Changes to KOSPI 200 and KOSDAQ 150

One trading idea post announcement of KOSPI 200 and KOSDAQ 150 rebalances is to highlight the potential underperformers (including 20 lowest market...

Douglas Kim

KRX Short Interest Weekly (Jun 5th): SAMSUNG C&T, NAVER, LG Electronics, LG Innotek, SamsungElecMech

We analyzed KRX short interest report for the past week and highlighted short interest changes in SAMSUNG C&T, NAVER, LG Electronics, LG Innotek,...

Ke Yan, CFA, FRM

KRX Short Interest Weekly (May 22nd): Mobis, HyundaiEng&Const, LG Display, DB HiTek, JEL

We analyzed KRX short interest report for the past week and highlighted short interest changes in Mobis, HyundaiEng&Const, LG Display, DB HiTek, JEL.

Ke Yan, CFA, FRM

KOSPI 200 and KOSDAQ 150 Indices Rebalance Announcements for June 2026

On 22 May, the Korea Exchange announced its regular bi-annual constituent rebalance changes in KOSPI 200 and KOSDAQ 150 indices, effective 12 June...

Douglas Kim

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)